Top Stock Reports for Mastercard, Procter & Gamble & Novartis
Today's Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), The Procter ...
BioSpace6h
Pfizer’s Ibrance Improves Survival in New Breast Cancer Indication
Pfizer, facing increasing pressure from Novartis, is touting a Phase III win for Ibrance as the first clinical evidence supporting the CDK4/6 inhibitor class’ use in patients with a specific type of ...
FiercePharma9h
SABCS: Under siege from competitors, Pfizer's Ibrance scores in double-positive breast cancer
While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...
STAT21h
Pfizer’s blockbuster Ibrance slows tumor progression in another type of breast cancer
Although not a game changer for Pfizer, the data could help cushion Ibrance’s losses of market share to Kisqali, a similar ...